Raffy Dakessian

Raffy Dakessian

University of Michigan - Ann Arbor / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 6025173
person_outline Raffy Dakessian's MOST POPULAR ARTICLES
1-) First-in-human phase I study of PRS-050 (Angiocal), an Anticalin targeting and antagonizing VEGF-A, in patients with advanced solid tumors PloS one 8 (12), e83232, 2013
2-) Jaagsiekte sheep retrovirus biology and oncogenesis Viruses 2 (12), 2618-2648, 2010
3-) A randomized phase (Ph) 2 study with exploratory biomarker analysis of ficlatuzumab (F) a humanized hepatocyte growth factor (HGF) inhibitory MAB in combination with gefitinib … Annals of Oncology 23, ix391, 2012
4-) Phase I ficlatuzumab monotherapy or with erlotinib for refractory advanced solid tumours and multiple myeloma British journal of cancer 111 (2), 272-280, 2014
5-) Phase I ficlatuzumab monotherapy or with erlotinib for refractory advanced solid tumours and multiple myeloma British journal of cancer 111 (2), 272-280, 2014